The OPPF-UK Pipeline for Structural Proteomics of Glycoproteins
Joanne Nettleship, Senior Scientist, Oxford Protein Production, speaking at Advances in Protein Crystallography 2010.
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Progression of HCV Infection to Hepatocellular Carcinoma
Radoslav Goldman, Associate Professor, Georgetown University, speaking at European Biomarkers Summit 2010.
A Novel Strategy for Bespoke Tissue-Specific Biomarkers for Drug Development
Gary Coulton, Director, University of London, speaking at European Biomarkers Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
Double Knockdown of Transcription Factors DP1 and DP2 Revealed Their Unique Roles in the Regulation of Matrix Metalloproteinase as Well as Cell Cycle Progression
Kenichi Yoshida, Associate Professor, Meiji University, speaking at European Biomarkers Summit 2009
Proteomics-Based Dynamic Response Networks (DRNet) and Their Clinical Applications
Serhiy Souchelnytskii, Karolinska Institute, Associate Professor, speaking at Cancer Proteomics 2010.
Mass Spectrometry Based Serum Protein Profiling for the Early Detection of Breast Cancer
Rob Tollenaar, Leiden University Medical Center, Professor of Surgical Oncology, speaking at Cancer Proteomics 2010.
Cancer Biomarkers for Diagnosis and Therapy Prediction
Ralph Schiess, ETH, Researcher, speaking at Cancer Proteomics 2010.